Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov 9;11(22):6643.
doi: 10.3390/jcm11226643.

Disease Activity and Progression in Multiple Sclerosis: New Evidences and Future Perspectives

Affiliations
Editorial

Disease Activity and Progression in Multiple Sclerosis: New Evidences and Future Perspectives

Ilaria Del Negro et al. J Clin Med. .

Abstract

Multiple sclerosis (MS) is a chronic, debilitating, autoimmune-mediated, inflammatory disease of the central nervous system (CNS), in which a combination of inflammation, demyelination and axonal degeneration takes place with extreme highly interpersonal variability [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Mirmosayyeb O., Brand S., Barzegar M., Afshari-Safavi A., Nehzat N., Shaygannejad V., Sadeghi Bahmani D. Clinical Characteristics and Disability Progression of Early and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis. J. Clin. Med. 2020;9:1326. doi: 10.3390/jcm9051326. - DOI - PMC - PubMed
    1. Ostini C., Bovis F., Disanto G., Ripellino P., Pravatà E., Sacco R., Padlina G., Sormani M.P., Gobbi C., Zecca C. Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple Sclerosis. J. Clin. Med. 2021;10:463. doi: 10.3390/jcm10030463. - DOI - PMC - PubMed
    1. Kapica-Topczewska K., Collin F., Tarasiuk J., Czarnowska A., Chorąży M., Mirończuk A., Kochanowicz J., Kułakowska A. Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland. J. Clin. Med. 2021;10:868. doi: 10.3390/jcm10040868. - DOI - PMC - PubMed
    1. Temmerman J., Van Der Veken F., Engelborghs S., Guldolf K., Nagels G., Smeets D., Allemeersch G.-J., Costers L., D’hooghe M.B., Vanbinst A.-M., et al. Brain Volume Loss Can Occur at the Rate of Normal Aging in Patients with Multiple Sclerosis Who Are Free from Disease Activity. J. Clin. Med. 2022;11:523. doi: 10.3390/jcm11030523. - DOI - PMC - PubMed
    1. Kulczyńska-Przybik A., Dulewicz M., Doroszkiewicz J., Borawska R., Litman-Zawadzka A., Arslan D., Kułakowska A., Kochanowicz J., Mroczko B. Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis. J. Clin. Med. 2022;11:4122. doi: 10.3390/jcm11144122. - DOI - PMC - PubMed

Publication types

LinkOut - more resources